Beers R - Search Results

1

Novel anti-CD30 recombinant immunotoxins containing disulfide-stabilized Fv fragments.

Nagata S, Onda M, Numata Y, Santora K, Beers R, Kreitman RJ, Pastan I. Nagata S, et al. Among authors: beers r. Clin Cancer Res. 2002 Jul;8(7):2345-55. Clin Cancer Res. 2002. PMID: 12114439

2

Improved cytotoxic activity toward cell lines and fresh leukemia cells of a mutant anti-CD22 immunotoxin obtained by antibody phage display.

Salvatore G, Beers R, Margulies I, Kreitman RJ, Pastan I. Salvatore G, et al. Among authors: beers r. Clin Cancer Res. 2002 Apr;8(4):995-1002. Clin Cancer Res. 2002. PMID: 11948105

3

New monoclonal antibodies to mesothelin useful for immunohistochemistry, fluorescence-activated cell sorting, Western blotting, and ELISA.

Onda M, Willingham M, Nagata S, Bera TK, Beers R, Ho M, Hassan R, Kreitman RJ, Pastan I. Onda M, et al. Among authors: beers r. Clin Cancer Res. 2005 Aug 15;11(16):5840-6. doi: 10.1158/1078-0432.CCR-05-0578. Clin Cancer Res. 2005. PMID: 16115924

4

Characterization of the B cell epitopes associated with a truncated form of Pseudomonas exotoxin (PE38) used to make immunotoxins for the treatment of cancer patients.

Onda M, Nagata S, FitzGerald DJ, Beers R, Fisher RJ, Vincent JJ, Lee B, Nakamura M, Hwang J, Kreitman RJ, Hassan R, Pastan I. Onda M, et al. Among authors: beers r. J Immunol. 2006 Dec 15;177(12):8822-34. doi: 10.4049/jimmunol.177.12.8822. J Immunol. 2006. PMID: 17142785

5

Differential cellular internalization of anti-CD19 and -CD22 immunotoxins results in different cytotoxic activity.

Du X, Beers R, Fitzgerald DJ, Pastan I. Du X, et al. Among authors: beers r. Cancer Res. 2008 Aug 1;68(15):6300-5. doi: 10.1158/0008-5472.CAN-08-0461. Cancer Res. 2008. PMID: 18676854 Free PMC article.

6

An immunotoxin with greatly reduced immunogenicity by identification and removal of B cell epitopes.

Onda M, Beers R, Xiang L, Nagata S, Wang QC, Pastan I. Onda M, et al. Among authors: beers r. Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11311-6. doi: 10.1073/pnas.0804851105. Epub 2008 Aug 4. Proc Natl Acad Sci U S A. 2008. PMID: 18678888 Free PMC article.

7

Recombinant immunotoxin against B-cell malignancies with no immunogenicity in mice by removal of B-cell epitopes.

Onda M, Beers R, Xiang L, Lee B, Weldon JE, Kreitman RJ, Pastan I. Onda M, et al. Among authors: beers r. Proc Natl Acad Sci U S A. 2011 Apr 5;108(14):5742-7. doi: 10.1073/pnas.1102746108. Epub 2011 Mar 21. Proc Natl Acad Sci U S A. 2011. PMID: 21436054 Free PMC article.

8

Immunotoxins with increased activity against epidermal growth factor receptor vIII-expressing cells produced by antibody phage display.

Beers R, Chowdhury P, Bigner D, Pastan I. Beers R, et al. Clin Cancer Res. 2000 Jul;6(7):2835-43. Clin Cancer Res. 2000. PMID: 10914732

9

Recombinant immunotoxins in the treatment of cancer.

Pastan I, Beers R, Bera TK. Pastan I, et al. Among authors: beers r. Methods Mol Biol. 2004;248:503-18. doi: 10.1385/1-59259-666-5:503. Methods Mol Biol. 2004. PMID: 14970517 No abstract available.

10

Releasable PEGylation of mesothelin targeted immunotoxin SS1P achieves single dosage complete regression of a human carcinoma in mice.

Filpula D, Yang K, Basu A, Hassan R, Xiang L, Zhang Z, Wang M, Wang QC, Ho M, Beers R, Zhao H, Peng P, Zhou J, Li X, Petti G, Janjua A, Liu J, Wu D, Yu D, Zhang Z, Longley C, FitzGerald D, Kreitman RJ, Pastan I. Filpula D, et al. Among authors: beers r. Bioconjug Chem. 2007 May-Jun;18(3):773-84. doi: 10.1021/bc060314x. Epub 2007 Mar 9. Bioconjug Chem. 2007. PMID: 17346030

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

154 results

Search Page